Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Annunziata

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
American Journal of Therapeutics|January 21, 2011
Targeting the proteasome with bortezomib in multiple myeloma: update on therapeutic benefit as an upfront single agent, induction regimen for stem-cell transplantation and as maintenance therapyJames J Driscoll, Jason Burris, Christina M Annunziata
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2016
Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer TreatmentKristen P Zeligs, Monica K Neuman, Christina M Annunziata
Oncotarget|November 16, 2017
PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphomaGeorgios N Pongas, Christina M Annunziata, Louis M Staudt
Prenatal Diagnosis|July 6, 2023
Patients' perspectives on prenatal screening results that suggest maternal cancer: A qualitative analysisAmy Turriff, Skye A Miner, Christina M Annunziata, et al.
Cell Death Discovery|June 5, 2021
Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanismLidia F Hernandez, Angie B Dull, Soumya Korrapati, et al.
Haematologica|April 29, 1998
Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemiaF Ferrara, M Annunziata, C Copia, et al.
European Review for Medical and Pharmacological Sciences|November 17, 2021
Cell-based therapies for the surgical treatment of periodontal intrabony defects: a systematic reviewG Cecoro, L Guida, A Iuorio, et al.
Cytokine & Growth Factor Reviews|March 31, 2016
Monocyte and interferon based therapy for the treatment of ovarian cancerDaniel S Green, Ana T Nunes, Christina M Annunziata, et al.
Journal of Clinical Gastroenterology|April 1, 1997
Candida (Torulopsis glabrata) liver abscesses eight years after orthotopic liver transplantationG M Annunziata, M Blackstone, J Hart, et al.
Oncotarget|December 5, 2014
Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21Marianne K Kim, Dong J Min, George Wright, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
American Journal of Therapeutics|January 21, 2011
Targeting the proteasome with bortezomib in multiple myeloma: update on therapeutic benefit as an upfront single agent, induction regimen for stem-cell transplantation and as maintenance therapyJames J Driscoll, Jason Burris, Christina M Annunziata
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2016
Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer TreatmentKristen P Zeligs, Monica K Neuman, Christina M Annunziata
Oncotarget|November 16, 2017
PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphomaGeorgios N Pongas, Christina M Annunziata, Louis M Staudt
Prenatal Diagnosis|July 6, 2023
Patients' perspectives on prenatal screening results that suggest maternal cancer: A qualitative analysisAmy Turriff, Skye A Miner, Christina M Annunziata, et al.
Cell Death Discovery|June 5, 2021
Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanismLidia F Hernandez, Angie B Dull, Soumya Korrapati, et al.
Haematologica|April 29, 1998
Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemiaF Ferrara, M Annunziata, C Copia, et al.
European Review for Medical and Pharmacological Sciences|November 17, 2021
Cell-based therapies for the surgical treatment of periodontal intrabony defects: a systematic reviewG Cecoro, L Guida, A Iuorio, et al.
Cytokine & Growth Factor Reviews|March 31, 2016
Monocyte and interferon based therapy for the treatment of ovarian cancerDaniel S Green, Ana T Nunes, Christina M Annunziata, et al.
Journal of Clinical Gastroenterology|April 1, 1997
Candida (Torulopsis glabrata) liver abscesses eight years after orthotopic liver transplantationG M Annunziata, M Blackstone, J Hart, et al.
Oncotarget|December 5, 2014
Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21Marianne K Kim, Dong J Min, George Wright, et al.
Pageof 14